Trials / Completed
CompletedNCT05184348
Plexin B2 Gene Expression and Polymorphisms in Psoriasis
Plexin B2 Gene Expression and Polymorphisms in Psoriasis : Relation to NB-UVB, Acitretin and Combined Therapy
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 200 (actual)
- Sponsor
- South Valley University · Academic / Other
- Sex
- All
- Age
- 24 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
Patients will be randomly assigned (1:1:1 ) either to ; NB-UVB photo-therapy alone , Acitretin therapy alone or NB-UVB photo-therapy combined with Acitretin therapy randomization will be done by closed envelopes . investigator will be blinded to study drug assignment , while patients and data interpreter will not be masked to study drug assignment.
Detailed description
Study Setting: Qena University Hospital, Department of Dermatology ,Venereology\& Andrology. Study subjects: the study will include psoriasis Vulgaris patients who Come to the out patients dermatologic clinic and matching inclusion \& exclusion criteria as follow, from 9/2021 up to 3/2023 and then patients will be divided to each group equally as follow: Group 1: Patients will be treated with NB-UVB phototherapy 3 sessions weekly for 3 months with maximum dose of 1400 mJ/cm2. Group 2: Patients will be treated with Acitretin in dose of 0.5-1 mg per kg per day orally for 3 months Group 3: Patients will be treated with Acitretin in dose of 0.5-1 mg per kg per day orally plus NB-UVB phototherapy 3 sessions weekly for 3 months with maximum dose 1400 mJ/cm2. Group 4: 30 healthy individuals un related , age, sex , BMI matched with volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Narrow band Ultraviolet B phototherapy group | 3 sessions weekly for 3 months with maximum dose 1400 mJ/cm2. |
| DRUG | Acitretin group | dose of 0.5-1 mg per kg per day orally for 3 month. |
| COMBINATION_PRODUCT | Acitretin plus Narrow band Ultraviolet B phototherapy group | Acitretin in dose of 0.5-1 mg per kg per day orally plus Narrow band Ultraviolet B phototherapy 3 sessions weekly for 3 months with maximum dose 1400 mJ/cm2. |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2023-01-30
- Completion
- 2023-03-30
- First posted
- 2022-01-11
- Last updated
- 2023-09-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05184348. Inclusion in this directory is not an endorsement.